Zero-total event trials and incomplete pyloromyotomy

Journal of Pediatric Surgery

Volumn 44, Issue 12, 2009, Pages 2434-2435

  Eaton, Simon ^a   Hall, Nigel J ^a   Pierro, Agostino ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EVIDENCE BASED PRACTICE; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LETTER; META ANALYSIS; PEDIATRIC SURGERY; PRIORITY JOURNAL; PYLOROMYOTOMY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

HUMANS; LAPAROSCOPY; META-ANALYSIS AS TOPIC; MUSCLE, SMOOTH; PYLORIC STENOSIS; PYLORUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME;

EID: 71649112441     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.08.028     Document Type: Letter

References (8)

1. Sola J.E., and Neville H.L. Laparoscopic vs open pyloromyotomy: a systematic review and meta-analysis. J Pediatr Surg 44 (2009) 1631-1637
2. Hall N.J., Pacilli M., Eaton S., et al. Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial. Lancet 373 (2009) 390-398
3. Leclair M.D., Plattner V., Mirallie E., et al. Laparoscopic pyloromyotomy for hypertrophic pyloric stenosis: a prospective, randomized controlled trial. J Pediatr Surg 42 (2007) 692-698
4. Greason K.L., Allshouse M.J., Thompson W.M.R., et al. A prospective, randomized evaluation of laparoscopic versus open pyloromyotomy in the treatment of infantile hypertrophic pyloric stenosis. Pediatr Endosurg Innovative Tech 1 (1997) 175-179
5. Peter S.D.M., Holcomb G.W.I., Calkins C.M.M., et al. Open versus laparoscopic pyloromyotomy for pyloric stenosis: a prospective, randomized trial. Ann Surg 244 (2006) 363-370
6. Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007) 2457-2471
7. Hernandez A.V., Walker E., Ioannidis J.P., et al. Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. Am Heart J 156 (2008) 23-30
8. Friedrich J.O., Adhikari N.K., and Beyene J. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 7 (2007) 5